Ogluo الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

ogluo

tetris pharma b.v - glucagon - diabetes mellitus - pancreas hormoner, hormoner glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.